Preferences for Advanced Parkinson’s Disease Treatments from People with Parkinson’s and Care Partners: Insights from a Discrete-choice Experiment (P4-5.023)
To elicit preferences of people with advanced Parkinson’s (PwaP) and care partners (CP), exploring the relative importance of treatment characteristics, and benefits-risks tradeoffs.
Authors
- Elaheh Shirneshan
- Marco Boeri (ORCID: https://orcid.org/0000-0001-7346-2132)
- Megha Shah (ORCID: https://orcid.org/0000-0002-6722-7846)
- К. Ray Chaudhuri (ORCID: https://orcid.org/0000-0003-2815-0505)
- Marieke Heisen
- Josefa Domingos (ORCID: https://orcid.org/0000-0001-9390-6183)
- Angelo Antonini (ORCID: https://orcid.org/0000-0003-1040-2807)
- Irene A. Malaty (ORCID: https://orcid.org/0000-0001-6914-9223)
- Hannah Penton (ORCID: https://orcid.org/0000-0001-9492-7875)
- Juan Carlos Parra (ORCID: https://orcid.org/0000-0002-5613-6121)
- Connie Yan (ORCID: https://orcid.org/0000-0002-9961-0671)
- Pablo Prieto (ORCID: https://orcid.org/0000-0001-5715-3743)
- Rajesh Pahwa
- Pavnit Kukreja
- Francesco De Renzis
Institutions
- Queen's University Belfast (GB)
- University of Padua (IT)
- The King's College (US)
- AbbVie (United States) (US)
- University of Florida (US)
- Parkinson's UK (GB)
- University of Kansas Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000209041
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00